Joseph Feder, Ph.D., co-founded ISTO Technologies, Inc. in 1997 and was President, CEO, and Chairman of the Company until 2003. He has served as Chairman and Director since 2003. Previously, he was the Principal of Joseph Feder Associates, a strategic planning and technology assessment consulting firm in the fields of biotechnology and biopharmaceuticals serving universities, research institutions and the venture capital community. Earlier, Dr. Feder was President and Chief Executive Officer of Invitron Corporation, a publicly held biotechnology company. From 1965 to 1989, Dr. Feder was a Distinguished Science Fellow and Director, Biochemistry and Cell Culture, at the Central Research Laboratories of Monsanto Company. He is the author of more than 130 scientific articles and 40 patents. Dr. Feder received his Ph.D. in biochemistry from Illinois Institute of Technology.
Mitchell Seyedin, Ph.D., joined ISTO in September 2003. Before joining ISTO Technologies, Dr. Seyedin served as President and CEO of CBYON Inc., which developed and marketed advanced image-guided surgical systems. In 1995, he founded Orquest, an orthobiologic company that developed biological products for orthopedic applications. He served as its CEO for the first two years, as its Chairman until October 2001, and as a Board member until its acquisition by Johnson & Johnson in January 2003. In 1990, Dr. Seyedin co-founded Metra Biosystems and served as Vice President of Research & Development. Metra developed and commercialized diagnostic tests for osteoporosis and cancer. In 1995, Metra went public and was later acquired by Quidel (NASDAQ:QDEL) in June 1999. Before founding Metra, Dr. Seyedin was the Director of Research at Collagen Corporation, where he was responsible for bone and cartilage research. Currently, he serves on the Board of Directors of BioSet Inc., a privately held biotechnology company. Dr. Seyedin holds a B.S. in Chemistry from the University of Wisconsin, a Ph.D. in Biochemistry from the University of South Carolina and completed his post-doctoral training at the University of California - Berkeley.
John Hart joined ISTO Technologies in July 2012 with over 30 years of medical device and life science experience. Prior to joining ISTO, Mr. Hart was President & CEO of Vidar Systems Corporation, a leading medical imaging company located in Herndon, Virginia, for five years. Prior to 2007, John held senior leadership positions in general management, marketing and sales with Stryker Orthopaedics and U.S. Surgical (now Covidien), including Vice President & General Manager, Vice President of Marketing, and Vice President of Sales. Mr. Hart holds a B.S. degree from The College of New Jersey and an MBA from Southern New Hampshire University.
Scott Gill joined ISTO Technologies in December 2007 with 15 years of investment banking and corporate finance experience. Prior to joining the Company, Mr. Gill was a Director with the Investment Banking group of A.G. Edwards & Sons, Inc. where he worked with a number of public and private emerging growth companies on a variety of corporate finance advisory assignments with a particular emphasis on M&A transactions for clients in the healthcare sector. Before joining A.G. Edwards, Mr. Gill was a Senior Financial Analyst with Anheuser-Busch, Inc. and a commercial banker with Bank of America. Mr. Gill received his Bachelor of Arts in economics from the University of Tennessee and his Master of Business Administration from the J.L. Kellogg School of Management at Northwestern University.
Penny White joined ISTO in May 2000 with 16 years of experience in the biopharmaceutical industry including serving as the Associate Director of Regulatory Affairs for Chiron Corporation, and prior to that as the Associate Director of Technical Affairs for Centocor, Inc. During that time she prepared numerous documents for submission to regulatory bodies, both U.S. and foreign, with successful outcomes leading to product approvals. She is a member of the Regulatory Affairs Professional Society with certification as a Regulatory Affairs Professional, and has a B.S. in Biology from Texas A&M University.
Gary Gage, who joined ISTO in January 2004, has 20 years of experience in the medical device industry. He has developed several products from concept to commercialization, and holds multiple patents. His medical product development tenure includes research and development and senior level management positions with Johnson & Johnson, Surgimedics, Medtronic and Abbott Laboratories. He holds a B.S. in Mechanical Engineering from Texas A&M University and is a Registered Professional Engineer.